Tags : Mogrify

Weekly Snapshot

PharmaShots Weekly Snapshot (April 20 -24, 2020)

1. Sanofi Receives the US FDA’s Approval for its MenQuadfi Meningococcal (MenACWY) Conjugate Vaccine Published: Apr 23, 2020 | Tags: Sanofi, Receives, US, FDA, Approval, MenQuadfi, Meningococcal, MenACWY, Conjugate Vaccine 2.  Takeda to Divest Select OTC and Non-Core Assets in Europe to Orifarm for $670M Published: Apr 24, 2020 | Tags: Takeda, Divest, Select OTC and […]Read More


Sangamo Signs an Exclusive License Agreement with Mogrify for iPSC

Shots: Shots: Mogrify to receive upfront, development, regulatory and commercial milestones and will be responsible for the discovery & optimization of the cell conversion technology from iPSCs or ESCs to regulatory T cells Sangamo to get exclusive rights to use Mogrify’s technology to develop Tregs from iPSCs/ESCs. The company anticipates utilizing its ZFP technology & […]Read More